Allworth Financial’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-766
Closed -$1K 3278
2022
Q2
$1K Hold
766
﹤0.01% 2338
2022
Q1
$1K Hold
766
﹤0.01% 2070
2021
Q4
$1K Hold
766
﹤0.01% 1891
2021
Q3
$1K Hold
766
﹤0.01% 1832
2021
Q2
$1K Sell
766
-500
-39% -$836 ﹤0.01% 1524
2021
Q1
$3K Sell
1,266
-10,000
-89% -$20.8K ﹤0.01% 1270
2020
Q4
$14K Hold
11,266
﹤0.01% 765
2020
Q3
$14K Hold
11,266
﹤0.01% 646
2020
Q2
$13K Hold
11,266
﹤0.01% 678
2020
Q1
$9K Hold
11,266
﹤0.01% 736
2019
Q4
$11K Hold
11,266
﹤0.01% 637
2019
Q3
$16K Hold
11,266
﹤0.01% 499
2019
Q2
$17K Hold
11,266
﹤0.01% 491
2019
Q1
$17K Buy
11,266
+500
+5% +$763 ﹤0.01% 489
2018
Q4
$16K Hold
10,766
﹤0.01% 448
2018
Q3
$20K Sell
10,766
-2,000
-16% -$3.88K ﹤0.01% 433
2018
Q2
$23K Buy
12,766
+2,766
+28% +$5.15K ﹤0.01% 389
2018
Q1
$20K Hold
10,000
﹤0.01% 374
2017
Q4
$11K Hold
10,000
﹤0.01% 464
2017
Q3
$12K Hold
10,000
﹤0.01% 447
2017
Q2
$13K Hold
10,000
﹤0.01% 444
2017
Q1
$20K Hold
10,000
﹤0.01% 366
2016
Q4
$21K Hold
10,000
﹤0.01% 317
2016
Q3
$17K Buy
+10,000
New +$12.2K ﹤0.01% 348

Allworth Financial's MBII Position: Q3 2022 in Review

Allworth Financial sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 766 shares — an estimated $1K sold.

Allworth Financial first reported a position in MBII in Q3 2016 and held it in 24 quarters. The position peaked at $23K in Q2 2018. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

  • Allworth Financial reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
  • Allworth Financial sold 766 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $1K.
  • Allworth Financial first reported a position in Marrone Bio Innovations, Inc. in Q3 2016 and held it in 24 quarters.
  • Allworth Financial's Marrone Bio Innovations, Inc. position peaked at $23K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Allworth Financial's 13F filing for Q3 2022, filed 18 Oct 2022.